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During 1998–2005, we analyzed stool samples from 
289 children in Rio de Janeiro to detect and genotype no-
rovirus strains. Previous tests showed all samples to be 
negative for rotavirus and adenovirus. Of 42 (14.5%) no-
rovirus-positive specimens, 20 (47.6%) were identiﬁ  ed as 
genogroup GI and 22 (52.3%) as GII.
N
oroviruses, a genus within the family Caliciviridae, 
have emerged as an important cause of epidemic and 
sporadic diarrheal disease in humans of all ages worldwide 
(1–3). The norovirus genome consists of a single strand of 
positive-sense RNA organized into 3 open reading frames 
(ORFs). ORF1 encodes nonstructural proteins such as RNA-
dependent RNA polymerase, ORF2 encodes viral capsid 
protein 1, and ORF3 encodes a small capsid protein (viral 
capsid protein 2) associated with stability of viral capsid pro-
tein 1 (4–6). According to nucleotide sequence analysis of 
the polymerase and capsid regions, noroviruses are classiﬁ  ed 
into 5 genogroups, GI to GV; each genogroup can be further 
divided into several clusters or genotypes. Genogroups GI, 
GII, and GIV have been found in humans, though GII seems 
to be the predominant strain around the world (4,7–11). To 
detect and genotype norovirus in stool samples from Brazil-
ian children <10 years of age who had acute diarrhea, we 
used real-time Light Cycler reverse transcription–PCR (RT-
PCR) and conventional RT-PCR assays.
The Study
From January 1998 through May 2005, a total of 2,421 
fecal specimens were collected from children <10 years 
of age (median age 2.3 years) with acute diarrhea in Rio 
de Janeiro, Brazil. Of these, 478 (19.7%) specimens were 
collected from hospitalized children (inpatients) and 1,943 
from outpatient children (341 [14.1%] from the emergency 
department and 1,602 [66.2%] from the walk-in clinic). Of 
these samples, 14.3% were positive for rotavirus (9.8%) or 
adenovirus (4.5%). The median age was 12.5 months for 
rotavirus-positive patients and 12.2 months for adenovirus-
positive patients. Overall, of the hospitalized, emergency 
department, and walk-in clinic patients, 11.7%, 6.2%, 
and 10.0%, respectively, had samples positive for rotavi-
rus, and 4.8%, 4.1%, and 4.4%, respectively, had samples 
positive for adenovirus. Enteropathogenic bacteria such as 
Escherichia coli, Salmonella spp., Yersinia enterocolitica, 
Campylobacter spp., and Shigella spp. were found in 8% 
of the specimens. Seven mixed infections were detected (2 
adenovirus and Salmonella spp., 2 adenovirus and E. coli, 
1 adenovirus and Campylobacter spp., 1 rotavirus and Sal-
monella spp., and 1 rotavirus and E. coli).
We selected 289 specimens that represented a random 
subset of samples that had prior negative results for rotavi-
rus and enteric adenovirus. Of these 289, 117 were collect-
ed from inpatients and 172 from outpatients (89 emergency 
department and 83 walk-in clinic). The mean and the me-
dian age of the tested patients was 3.1 years. Suspensions 
of stool (10%) were prepared in diethylpyrocarbonate-
treated water and Vertrel XF (Miller-Stephenson, Sylmar, 
CA, USA) and clariﬁ  ed by centrifugation at 2,100× g for 
10 min. We used 200 μL of suspension for RNA extraction 
with the NucliSens extraction kit (Organon Tekninka, Dur-
ham, NC, USA) according to the manufacturer’s instruc-
tions. The RNA was eluted in 50 μL of elution buffer and 
stored at –70°C until use.
A total of 240 samples were tested for norovirus 
RNA by Light Cycler PCR that used primers and probes 
for ORF1/ORF2 junction region speciﬁ  c for norovirus GI 
and GII, as described (3,12), and by the Light Cycler RNA 
Ampliﬁ   cation Kit Hybridization Probes (Roche, Basel, 
Switzerland). Samples that showed a positive threshold 
at <38 cycles were considered positive. The 49 remain-
ing samples were tested only by conventional RT-PCR, as 
described (5). Conventional RT-PCR was performed with 
the QIAGEN OneStep RT-PCR Kit (QIAGEN, Valencia, 
CA, USA). The RNA samples were subjected to 1 cycle of 
reverse transcription (42°C, 10 min) followed by 5 min at 
95°C. PCR was performed for 40 cycles, each consisting of 
1 min at 94°C, 1 min at 40°C (for GI detection) or 1 min 
at 44°C for (for GII detection), 1 min at 72°C, and a ﬁ  nal 
extension cycle of 10 min at 72°C.
We selected 6 samples that were positive by real-time 
Light Cycler PCR (2 GI and 4 GII) for analysis by conven-
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tional RT-PCR with speciﬁ  c primers in capsid region D of 
norovirus GI and GII, as described above. The ampliﬁ  ed 
cDNA samples were puriﬁ  ed from the gel by using QIA-
quick gel extraction kit (QIAGEN), and the sequences were 
determined with the BigDye terminator cycle sequencing 
kit and the ABI PRISM 3100 automated DNA sequencer 
(Applied Biosystems, Foster City, CA, USA) by using the 
same primers as used for the conventional RT-PCR. The 
nucleotide sequences of the amplicons were aligned with 
corresponding sequences of selected norovirus strains 
available in the GenBank database and analyzed by using 
the CLUSTAL V algorithm of the MegAlign program in the 
DNASTAR software package (Madison, WI, USA). The 
nucleotide sequences obtained in this study were deposited 
in GenBank under accession nos. DQ496212, DQ496213, 
DQ496214, DQ496215, DQ496216, and DQ496217.
Of the 289 fecal specimens tested, 42 (14.5%) were 
positive for norovirus: 36 (15%; n = 240) by real time Light 
Cycler PCR and 6 (12.2%; n = 49) by conventional RT-
PCR. These percentages correspond only to single infec-
tions because we did not test samples already known to be 
positive for other pathogens such as rotavirus and adenovi-
rus. Positive samples and genogroups varied by year with 
no obvious yearly pattern (Table 1). Although norovirus is 
often referred to as “the winter vomiting disease,” we de-
tected infection throughout the year, with no seasonal pat-
tern (Figure). Norovirus infections were equally common 
among outpatients and inpatients. Among 117 inpatients, 
18 (15.4%) had positive norovirus test results compared 
with 24 (14%) of 172 outpatients (11 emergency depart-
ment and 13 walk-in clinic). Although the disease caused 
by norovirus is described as mild (diarrhea, vomiting, ab-
dominal pain, and fever) and generally does not lead to 
hospitalization (13,14), of 42 norovirus-infected children, 
29 (69%) were either hospitalized or received medical care 
in the emergency department, which suggests that they 
had a more severe illness. Only 13 (31%) of the 42 noro-
virus-infected children attended the walk-in clinic, which 
suggests that they had mild disease (Table 2). Other than 
diarrhea, fever was the most common symptom among the 
42 norovirus-positive patients in this study, reported for 
11 (26.2%) patients. Vomiting only was described for 8 
(19.0%); vomiting and fever was described for 6 (14.3%). 
No mixed infection with bacteria was observed.
Although norovirus belonging to genogroup GII is con-
sidered the most prevalent strain worldwide (7–9,11,15), 
we found no important difference in the prevalence of the 2 
genogroups detected in our study. Overall, 20 (48%) of the 
42 samples were identiﬁ  ed as genogroup GI and 22 (52%) 
as GII (Table 1). No statistically signiﬁ  cant difference in 
the prevalence of GI and GII was observed between inpa-
tients and outpatients.
Conclusions 
Our study documents that noroviruses are a common 
cause of acute gastroenteritis in children who are inpatients 
or outpatients in Brazil and are likely second only to rota-
virus as a cause of severe childhood diarrhea. Our study 
was exploratory and has limitations. Nonetheless, it docu-
ments how common norovirus infections may be and indi-
Table 1. Distribution of norovirus-positive samples detected in Rio de Janeiro, Brazil, 1998–2005* 
Real-time reverse transcription–PCR  Conventional reverse transcription–PCR 
Year 
No. samples
tested
No. positive 
samples/genogroup 
No. samples 
tested
No. positive 
samples/genogroup 
Total no. positive 
samples/genogroup 
1998 23 4/3GI + 1GII  0 NA 4/3GI + 1GII 
1999 29 3/GII 5 1/GI 4/1GI + 3GII 
2000 31 4/2GI + 2GII  7 0 4/2GI + 2GII 
2001 26 4/GII 0 NA 4/GII
2002 31 5/4GI + 1GII  10 0 5/4GI + 1GII 
2003 32 8/5GI + 3GII  9 1/GI 9/6GI + 3GII 
2004 39 4/1GI + 3GII  16 3/GI 7/4GI + 3GII 
2005 29 4/GII 2 1/GII 5/5GII
Total 240 36/15GI + 21GII  49 6/5GI + 1GII  42/20GI + 22GII 
*NA, not applicable. 
Figure. Seasonal distribution of norovirus (NoV) infections in Rio de 
Janeiro, Brazil, 1998–2005.DISPATCHES
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cates that further study will be necessary to assess their role 
among Brazilian children, to understand the epidemiology 
of the disease, and to seek evidence of immunity in chil-
dren, which might encourage development of a vaccine.
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Table 2. Distribution of all tested samples by age groups and patient status, Rio de Janeiro, Brazil, 1998–2005 
Outpatients Inpatients
Age, y  No. tested 
PCR-positive,
no. (%) 
PCR-negative,  
no. (%)   No. tested 
PCR-positive,
no. (%) 
PCR-negative,  
no. (%) 
<1 29 4 (13.8)  25 (86.2)  45 5 (11.1)  40 (88.9) 
1–5 64 9 (14.0)  55 (86.0)  88 15 (17.0)  73 (83.0) 
6–10 24 5 (20.8)  19 (79.2)  39 4 (10.3)  35 (89.7) 
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